Li Zeng
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 6
- Cancer, Lipids, and Metabolism 4
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms 8
- Molecular Biology top 10%
- RNA modifications and cancer 8
- Ubiquitin and proteasome pathways 4
- RNA Research and Splicing 4
- Developmental Biology and Gene Regulation 4
- Geriatrics and Gerontology top 10%
- Cell Biology top 10%
-
- Silk-based biomaterials and applications 4
- Co-authors
- Andrew B. LassarL. Charles MurtaughClaire M. PerksHervé KempfDana M. CairnsWeishuai LianMaoquan LiTao Tang
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Li Zeng
75 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 159
- Cancer Research 381
- Rheumatology 265
- Molecular Biology 1000
- Geriatrics and Gerontology 40
- Cell Biology 148
Countries citing papers authored by Li Zeng
This map shows the geographic impact of Li Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zeng more than expected).
Fields of papers citing papers by Li Zeng
This network shows the impact of papers produced by Li Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zeng. The network helps show where Li Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 14 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 0 | |
| 11 | 2022 | 14 | |
| 12 | 2018 | 86 | |
| 13 | 2017 | 37 | |
| 14 | 2015 | 25 | |
| 15 | Mechanism and Effects of AM Fungi on Medicinal Plants | 2014 | 1 |
| 16 | 2013 | 71 | |
| 17 | 2010 | 20 | |
| 18 | 2008 | 39 | |
| 19 | 2004 | 9 | |
| 20 | 2001 | 112 |
About Li Zeng
Li Zeng is a scholar working on Life-span and Life-course Studies, Cancer Research and Rheumatology, having authored 79 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Osteoarthritis Treatment and Mechanisms (8 papers), Cancer-related molecular mechanisms research (6 papers), Silk-based biomaterials and applications (4 papers), Ubiquitin and proteasome pathways (4 papers), Cancer, Lipids, and Metabolism (4 papers), RNA Research and Splicing (4 papers) and Developmental Biology and Gene Regulation (4 papers). The work is most often cited by research in Cancer Research (381 citations), Rheumatology (265 citations) and Molecular Biology (1000 citations). Li Zeng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Andrew B. Lassar, L. Charles Murtaugh, Claire M. Perks, Hervé Kempf, Dana M. Cairns, Weishuai Lian, Maoquan Li, Tao Tang, Chuanwu Cao and Jing Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.